MEDICLINIC INTERNATIONAL LIMITED - Mediclinic acquires pathology laboratory operations in Dubai
MDC 201311210048A
Mediclinic acquires pathology laboratory operations in Dubai
Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
Share Code: MDC
("Mediclinic")
MEDICLINIC ACQUIRES PATHOLOGY LABORATORY OPERATIONS IN DUBAI
Mediclinic announces the acquisition of the two pathology
laboratories at Mediclinic Welcare Hospital and Mediclinic Al
Sufouh in Dubai for a cash consideration of AED95 million (R262
million) with effect from 1 October 2013.
The acquisition is expected to add AED19 million of annualised
incremental Earnings before Interest, Taxation, Depreciation and
Amortisation (EBITDA).
The acquisition supports the strategy of Mediclinic Middle East to
establish a centralised and reference laboratory that will yield
operational and clinical benefits.
Stellenbosch
21 November 2013
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 21/11/2013 02:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
